Pharmanutra S.p.A. (BIT:PHN)

Market Cap	443.19M
Revenue (ttm)	116.15M
Net Income (ttm)	16.61M
Shares Out	9.60M
EPS (ttm)	1.73
PE Ratio	26.70
Forward PE	20.30
Dividend	1.00 (2.17%)
Ex-Dividend Date	May 5, 2025

Volume	5,423
Average Volume	6,762
Open	46.05
Previous Close	46.15
Day's Range	45.75 - 46.45
52-Week Range	45.05 - 61.20
Beta	0.29
RSI	41.11
Earnings Date	Sep 8, 2025

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and softwar...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 118
• Stock Exchange: Borsa Italiana
• Ticker Symbol: PHN

Financial Performance

In 2024, Pharmanutra's revenue was 116.15 million, an increase of 15.33% compared to the previous year's 100.71 million. Earnings were 16.61 million, an increase of 29.43%.